Does an AI prevent growth plate closure from test or not?

gaysigmamax

gaysigmamax

Silver
Joined
Apr 16, 2025
Posts
728
Reputation
558
Title.

DNR anyone that tells me to do my own research.
 
  • +1
Reactions: oyjah, fraudster#1 and primal_shitmuncher
@darodiddler
 
  • +1
Reactions: primal_shitmuncher
Yes.

Estrogen drives growth plate closure in men.

Testosterone converts into estrogen via the aromatase enzyme.

At supraphysiological levels of test, there's high levels of estrogen due to the conversion.

This leads to sides such as mood swings, bloat, gyno, and growth plate closure.

Taking an aromatase inhibitor blocks the aromatase enzyme, thus lessening the amount of estrogen produced on cycle.

This would produce the estrogen related sides provided above, including early growth plate closure.

These threads should be helpful:


 
  • +1
  • JFL
Reactions: Wuffy101, Zagro, alexbrown8384 and 5 others
Yes.

Estrogen drives growth plate closure in men.

Testosterone converts into estrogen via the aromatase enzyme.

At supraphysiological levels of test, there's high levels of estrogen due to the conversion.

This leads to sides such as mood swings, bloat, gyno, and growth plate closure.

Taking an aromatase inhibitor blocks the aromatase enzyme, thus lessening the amount of estrogen produced on cycle.

This would produce the estrogen related sides provided above, including early growth plate closure.
heards sum shot abt local estrodiol rising in ur growth plates, ty
 
  • +1
Reactions: primal_shitmuncher
then localised aromatization walks in
@peterk1287
 
  • JFL
Reactions: primal_shitmuncher
maybe it does.

i dunno.

i hardly know anything about pharma, sorry if there's misinfo.
dude is this shit true, or is it just speculation
Erb
 
  • Woah
Reactions: primal_shitmuncher
damn im stupid

what does prevent it then?
very minimal test base + non-aromatizable androgen |||dht derivative can be optimal does to competition on ER|||
and total ER agonism
tamoxifen to keep AF1 of ERa intact, like 40 mg ed
keeping e2 below 10 pg/ml with exemestane, adjust the dosage in base on bloodworks
ERB041 25mg, which i dont have a source
 
  • +1
Reactions: primal_shitmuncher
Have people just forgotten about google?
 
Yes.

Estrogen drives growth plate closure in men.

Testosterone converts into estrogen via the aromatase enzyme.

At supraphysiological levels of test, there's high levels of estrogen due to the conversion.

This leads to sides such as mood swings, bloat, gyno, and growth plate closure.

Taking an aromatase inhibitor blocks the aromatase enzyme, thus lessening the amount of estrogen produced on cycle.

This would produce the estrogen related sides provided above, including early growth plate closure.

These threads should be helpful:


Never give out advice
 
  • +1
  • So Sad
Reactions: fraudster#1 and primal_shitmuncher

Similar threads

doidfestroyer
Replies
4
Views
79
daudthe1_
daudthe1_
blinkers
Replies
17
Views
152
Wuffy101
Wuffy101
A
Replies
4
Views
36
stigmaboy
stigmaboy
AlienatedParanoi_A
Replies
7
Views
33
darodiddler
darodiddler
M
Replies
2
Views
21
ZyzzReincarnate
ZyzzReincarnate

Users who are viewing this thread

Back
Top